p>"We believe our new technology will improve the dynamics of the
process, allowing NutraCea to achieve significantly higher value
end-products. NutraCea will incorporate its new technology into these
facilities during the first year of operation and should realize the
benefits of the incremental profits in the year 2009. We look to capitalize
on this proprietary technology in future opportunities that might become
available to us," said Brad Edson, President and Chief Executive Officer of
NutraCea.
"The consumer trend away from trans fatty acids and the global demand
for more healthful choices in edible oils has helped to drive rice bran oil
prices higher. With the purchase of this new facility, we are poised to
take advantage of the growing worldwide demand for healthy, edible oil and
create new, patented and proprietary value-added derivatives from rice
bran, utilizing technologies developed at NutraCea," said Leo Gingras,
Chief Operating Officer of NutraCea.
Edson, continued, "As we have stated in the past, the establishment of
our facilities in the major, rice-growing regions around the world is
essential to our long-term, strategic growth plan. We believe our Brazilian
facility will provide NutraCea with the opportunity for increasing revenues
going forward, not just for stabilized rice bran, but also for healthful
edible oils and value-added products derived from the rice bran and oil."
The Company will continue to negotiate other supply agreements for rice
bran, which will provide the raw material necessary to produce NutraCea's
proprietary stabilized rice bran and value-added derivative products.
About NutraCea
NutraCea is a leader in stabilized rice bran nutrient research and
dietary supplement development. Through its wholly owned subsidiary RiceX,
the company manufactures as well as distributes products and food
ingredients made from Rice Bran through its proprietary technology and
processes. The Company has developed i
'/>"/>
SOURCE NutraCea Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related medicine news :1.
NutraCea Files Universal Shelf Registration Statement2.
NutraCea Provides Update on Domestic Operations3.
NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran4.
NutraCea Announces Conference Call to Report Second Quarter Financial Results5.
NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 146.
NutraCea Appoints Financial Relations Board as New Investor Relations Firm7.
Perrigo Company Authorizes Continuation of Share Repurchase Program and Announces Quarterly Dividend8.
Delray Beach Mayor Commemorates Diagnostic Centers of America (DCA) $2 Million Purchase from Siemens to Become Only Medical Facility in South Florida with Worlds Most Advanced Cardiac Scanner.9.
Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1%10.
Abbey Spanier Rodd & Abrams, LLP Files Class Action Lawsuit on Behalf of Purchasers of American Dental Partners, Inc. Securities11.
Gerresheimer Finalises Purchase of Spanish Company EDP